These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3001383)

  • 1. [A case of male breast cancer with special reference to the hormonal environment during chemoendocrine therapy].
    Saito K; Hotta T; Kobayashi S; Miura I; Sakuma S; Shimozato T; Torii T; Iwase H; Satake A; Nishida T
    Gan No Rinsho; 1985 Oct; 31(13):1727-30. PubMed ID: 3001383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carcinoma of the male breast and hormone receptors].
    Bottero G; Novella V; Spinoglio G
    Minerva Med; 1988 Apr; 79(4):281-4. PubMed ID: 2835712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
    Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
    Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between estrogen and progesterone receptors and response to hormone therapy].
    Leclercq G; Paridaens R; Heuson JC
    Pathol Biol (Paris); 1983 Dec; 31(10):793-800. PubMed ID: 6366700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The hormonal therapy and steroid receptor analysis in advanced carcinoma of the breast (author's transl)].
    von Maillot K
    Geburtshilfe Frauenheilkd; 1979 Mar; 39(3):177-86. PubMed ID: 220135
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast cancer--topics from basic research].
    Matsumoto K; Kuroda H; Takeyama M
    Gan To Kagaku Ryoho; 1984 May; 11(5):974-80. PubMed ID: 6721515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steroid hormone receptors in breast cancer].
    Moyano C; Puga J; Calaf G; Rojas C
    Rev Chil Obstet Ginecol; 1984; 49(1):15-25. PubMed ID: 6099905
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone receptor analysis and cytostatic agent sensitivity testing. Significance in additional therapy planning of breast carcinoma].
    Schlag P; Schreml W; Veser J; Herfarth C
    Dtsch Med Wochenschr; 1981 Dec; 106(51-52):1749-54. PubMed ID: 6276119
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormonal receptors and breast cancer. Review of the literature and personal experience].
    Gallo A; Baldi F; Giannantoni C; Dell'Agli P; Caselli G
    Minerva Chir; 1988 Mar; 43(5):429-32. PubMed ID: 2840607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Estrogen receptors and clinical prognostic factors in breast cancer].
    Hernández JL; Lera JM; Fakih A; Gómez Portilla A; Vicente F; Zornoza G
    Rev Esp Oncol; 1983; 30(2):179-88. PubMed ID: 6097962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of hormone receptor analysis for diagnosis and therapy of gynecologic malignancies].
    Gitsch E; Salzer H
    Wien Klin Wochenschr; 1983 May; 95(11):385-8. PubMed ID: 6310902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptors in breast cancer; relationship to age, menstrual status and histological type.
    Gómez P; Luna G; Beltrán ME; Hernández F
    Arch Invest Med (Mex); 1987; 18(1):31-6. PubMed ID: 2820332
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of the study of hormonal receptors in the treatment of breast carcinoma (case report)].
    Carli C; Botto A; Podestà AM; Bottino S
    Pathologica; 1985; 77(1049):349. PubMed ID: 3008071
    [No Abstract]   [Full Text] [Related]  

  • 15. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statistical analysis of lectin and hormone receptor findings in 306 breast cancers].
    Hülter FW; Schumacher M; Kunze WP
    Verh Dtsch Ges Pathol; 1985; 69():359-61. PubMed ID: 3006386
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progesterone receptors in breast cancer].
    Vitola GIa; Zeĭkate GA; Grabovska IK
    Vopr Onkol; 1987; 33(9):35-8. PubMed ID: 3660754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast.
    Boland GP; McKeown A; Chan KC; Prasad R; Knox WF; Bundred NJ
    Br J Cancer; 2003 Jul; 89(2):277-83. PubMed ID: 12865917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the receptor composition of breast tumors with their histological structure; effect of preoperative therapy].
    Kuz'mina ZV; Murav'eva NI; Ermilova VD; Vishniakova VV; Letiagin VP
    Vestn Akad Med Nauk SSSR; 1985; (8):83-7. PubMed ID: 2998115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Steroid hormone receptors in breast cancer (a review of the literature)].
    Korolev VI; Dziubko NIa; Tarutinov VI
    Vrach Delo; 1988 Nov; (11):86-91. PubMed ID: 2853492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.